2 weeks Ago By ABMN Staff
Shares of Nuformix plc ( LON:NFX – Get Free Report ) dropped 11.9% on Tuesday . The company traded as low as GBX 0.
05 ($0.00) and last traded at GBX 0.05 ($0.
00). Approximately 14,879,378 shares were traded during mid-day trading, an increase of 182% from the average daily volume of 5,271,314 shares. The stock had previously closed at GBX 0.
06 ($0.00). Nuformix Stock Down 11.
9 % The company has a current ratio of 1.12, a quick ratio of 3.35 and a debt-to-equity ratio of 1.
17. The firm has a 50 day moving average price of GBX 0.16 and a 200-day moving average price of GBX 0.
18. The firm has a market cap of £426,041.20, a price-to-earnings ratio of -1.
63 and a beta of 1.22. Nuformix Company Profile ( Get Free Report ) Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom.
It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. Featured Articles Receive News & Ratings for Nuformix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuformix and related companies with MarketBeat.
com's FREE daily email newsletter ..
